Proprietary PEF Technology And Catalytic PlatformAvantium’s proprietary PEF and catalytic technologies align with a structural shift to biobased packaging and chemicals. Owning core IP supports licensing, differentiation from commodity producers, and potential scale economies—durable advantages if commercialization and volume production progress.

Diversified Commercial Revenue StreamsMultiple revenue sources—licensing, product sales and funded R&D—reduce single‑source dependency and provide varied monetization routes. Partnerships with large chemical players offer commercialization pathways and external funding that structurally de‑risk scale‑up and market entry over the medium term.

Sustained Top‑line Growth (2023–2024)Reported 6.8% revenue growth indicates market traction for Avantium’s biobased offerings. Sustained top‑line expansion supports future scale economics and validates demand, creating a foundation for eventual margin improvement if operational efficiency and commercialization scale follow.

Bears Say

Negative And Declining Free Cash FlowPersistent negative free cash flow and a recent 4.8% decline signal structural cash generation weakness. This constrains the company’s ability to fund plant scale‑up, commercialization and R&D internally, increasing dependence on external financing and raising dilution or refinancing risk over the medium term.

Consistent Negative Margins And UnprofitabilityOngoing negative gross, operating and net margins point to structural profitability issues—whether from pricing, input costs, or scale inefficiencies. Without durable margin improvement, the firm will struggle to achieve self‑sustaining operations and will remain reliant on external capital for growth.

Elevated Leverage And Weaker Equity RatioA debt‑to‑equity ratio of 1.56 and a falling equity ratio to 33.2% reflect elevated leverage for a capital‑intensive scale‑up. Higher indebtedness increases interest burden and refinancing risk, reducing financial flexibility to invest in commercial capacity or absorb industry shocks over the medium term.

0RNP FAQ

What was Avantium N.V.’s price range in the past 12 months?

Avantium N.V. lowest share price was €0.47 and its highest was €13.12 in the past 12 months.

What is Avantium N.V.’s market cap?

Avantium N.V.’s market cap is €169.89M.

When is Avantium N.V.’s upcoming earnings report date?

Avantium N.V.’s upcoming earnings report date is Mar 25, 2026 which is in 28 days.

How were Avantium N.V.’s earnings last quarter?

Avantium N.V. released its earnings results on Aug 13, 2025. The company reported -€0.713 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.713.

Is Avantium N.V. overvalued?

According to Wall Street analysts Avantium N.V.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Avantium N.V. pay dividends?

Avantium N.V. pays a Notavailable dividend of €0.285 which represents an annual dividend yield of N/A. See more information on Avantium N.V. dividends here

What is Avantium N.V.’s EPS estimate?

Avantium N.V.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Avantium N.V. have?

Avantium N.V. has 25,206,718 shares outstanding.

What happened to Avantium N.V.’s price movement after its last earnings report?

Avantium N.V. reported an EPS of -€0.713 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.493%.

Which hedge fund is a major shareholder of Avantium N.V.?

Currently, no hedge funds are holding shares in GB:0RNP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Avantium N.V.

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, the company R&D system, services, and refinery catalyst testing services. Further, it develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, the company produces polyesters using plantMEG. Avantium N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands.